Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial. - Aronne LJ; Horn DB; le Roux CW; Chao AM; Ho W; Halpern B; Griffin R; Xie C; Valderas EG; Lee CJ; Ribeiro A; Hyman DM; et al. (Nature medicine, 2026)